Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Feb 27 | JAZZ | Jazz Pharmaceuticals plc | SSELL | 1,117 | $190.91 | $213.2K | -10.8% | Open the original filing on SEC.gov |
| Feb 26 | JAZZ | Jazz Pharmaceuticals plc | SSELL | 1,253 | $194.11 | $243.2K | -10.8% | Open the original filing on SEC.gov |
| Feb 26 | JAZZ | Jazz Pharmaceuticals plc | AGRANT | 2,223 | — | — | +23.7% | Open the original filing on SEC.gov |
| Jan 16 | JAZZ | Jazz Pharmaceuticals plc | AGRANT | 2,370 | — | — | +33.8% | Open the original filing on SEC.gov |
| Dec 5, 2025 | JAZZ | Jazz Pharmaceuticals plc | MEXER◆ | 4,500 | — | — | — | Open the original filing on SEC.gov |
| Dec 5, 2025 | JAZZ | Jazz Pharmaceuticals plc | SSELL | 4,500 | $171.20 | $770.4K | -39.1% | Open the original filing on SEC.gov |
| Dec 5, 2025 | JAZZ | Jazz Pharmaceuticals plc | MEXER | 4,500 | $140.67 | $633K | +64.2% | Open the original filing on SEC.gov |
| Dec 5, 2025 | JAZZ | Jazz Pharmaceuticals plc | SSELL | 160 | $171.11 | $27.4K | -2.2% | Open the original filing on SEC.gov |